{"transactions":[{"id":3201959,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":150497,"kind":"person","name":"Slatko Gary H","position":1,"cik":"0001763416","reported_name":"Slatko Gary H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-03-18T20:48:39.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The units subject to the Award shall vest 25% 1st year, 25% 2nd year and 50% 3rd year on the commencement anniversaries."}],"balance_after":50000,"derivative":{"exercise_price":1.54,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001214659-20-002754","document":"marketforms-48341.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465920002754/marketforms-48341.xml","form_type":"4"}},{"id":3701717,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":150497,"kind":"person","name":"Slatko Gary H","position":1,"cik":"0001763416","reported_name":"Slatko Gary H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2019-01-07T16:28:16.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest in three annual installments of 25%, 25% and 50% on January 2, 2020, January 2, 2021 and January 2, 2022, respectively, subject in each case to Dr. Slatko's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":75000,"derivative":{"exercise_price":7.18,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001214659-19-000170","document":"marketforms-43687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465919000170/marketforms-43687.xml","form_type":"4"}}]}